Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Mouse Monoclonal Antibodies Against Human IKKgamma/NEMO Protein
Case ID:
TAB-743
Web Published:
12/6/2022
NF-kB has been found to be important in immune responses, cell proliferation, apoptosis, and in organ development. Several years ago it was discovered that an IKKgamma/NEMO protein was essential as an adaptor molecule to mediate TNF-alpha, IL-1, and oncoprotein induced activation of NF-kB. Mutation in IKKgamma/NEMO also results in two human genetic diseases, Familial incontinentia pigmenti and hypohidrotic/anhidrotic ectodermal dysplasia. The NIH announces mouse monoclonal antibodies to IKKgamma/NEMO that are far superior to other immunological reagents. It is anticipated that the antibodies would have both research and diagnostic capabilities.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech?title=Mouse_Monoclonal_Antib odies_Against_Human_IKKgamma%2fNEMO_Protein
Keywords:
Ectodermal dysplasia
IAXXXX
IDXXXX
Incontinentia pigmenti
IXXXXX
Neurofibromatosis type 2
Neurofibromatosis type 3
NF 2
NF 3
RXXXXX
Bookmark this page
Download as PDF
For Information, Contact:
Carol Salata
Technology Development Manager
NIH Technology Transfer
240-627-3727
csalata@mail.nih.gov